Orchid Pharma is a pharmaceutical company engaged in the development and manufacture of active pharmaceutical ingredients (APIs) and finished dosage forms. It is also engaged in research of new drugs.
Financial Results:
- Orchid Pharma Ltd. reported Total Income for Q4FY23 of ₹ 212 Crores up from ₹ 180 Crore year on year, a rise of 18%.
- Total Expenses for Q4FY23 of ₹ 185 Crores up from ₹ 183 Crores year on year, rise of 1%.
- Consolidated Net Profit of ₹ 59 Crores, up from a loss of ₹ 7 Crores in the same quarter of the previous year.
- The Earnings per Share is ₹ 14.49, up from ₹ -1.61 in the same quarter of the previous year.
